Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07925853
NA

Bioavailability of Two Mitopure Formulations

Sponsor: Amazentis SA

View on ClinicalTrials.gov

Summary

This study's design as an open-label, single-period, single-dose, randomized trial that aligns with the objective of characterizing the concentration-time profiles of two Urolithin A (Mitopure) formulations in a controlled setting. The inclusion criteria, stringent fasting requirements, standardized fluid intake and strict dietary restriction protocols ensure homogeneity among the study participants, enhancing the reliability of the outcomes. Ultimately, this clinical trial aims to contribute valuable insights into the pharmacokinetic behavior of the different Urolithin A formulations, facilitating informed decisions for future developments and applications in the realm of health and wellness.

Official title: The Bioavailability and Pharmacokinetic Profile of Distinct Urolithin A (Mitopure) Formulations in Healthy Adults: A Randomized, Open-Label, Single-Dose, Parallel-Arm Study

Key Details

Gender

All

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2026-12-01

Completion Date

2027-03-31

Last Updated

2026-11-13

Healthy Volunteers

Yes

Conditions

Interventions

DIETARY_SUPPLEMENT

Mitopure (Urolithin A)

Mitopure (Urolithin A) is gut microbiome derived postbiotic that has been shown to improve muscle and mitochondrial health. One dose of Formulation A will be consumed orally.

DIETARY_SUPPLEMENT

Mitopure (Urolithin A)

Mitopure (Urolithin A) is gut microbiome derived postbiotic that has been shown to improve muscle and mitochondrial health. One dose of Formulation B will be consumed orally.